ACOG Recommendations Highlight Importance of Influenza Vaccination for Pregnant women

A recent set of recommendations from the American College of Obstetricians and Gynecologists (ACOG) underscores the critical role of influenza vaccination for pregnant individuals in preventing severe complications. The recommendations, backed by the Centers for Disease Control and Prevention (CDC), emphasize the significance of timely immunization against influenza and provide guidance for obstetrician-gynecologists in managing respiratory illnesses during pregnancy.

  • Vaccination During Pregnancy: ACOG and CDC strongly advocate for influenza vaccination in pregnant individuals during the flu season, recommending an inactivated or recombinant influenza vaccine as soon as it becomes available. While October is an ideal timeframe, vaccination at any point during the flu season is encouraged for safeguarding against prevalent circulating viruses.
  • Safe Vaccination Practices: The recommendations highlight the safety and efficacy of influenza vaccination during pregnancy, supporting its administration irrespective of prior vaccine doses received in previous pregnancies. Studies consistently demonstrate the benefits of maternal immunization in protecting both pregnant individuals and their newborns against influenza-related complications.
  • Respiratory Illness Assessment and Treatment: Healthcare professionals should assess pregnant individuals presenting with respiratory symptoms for both influenza and SARS-CoV-2 infection, initiating prompt antiviral treatment within 48 hours of symptom onset for suspected influenza cases. Additionally, considering the potential co-infection of influenza and SARS-CoV-2, clinicians recommend specific antiviral treatments in such instances.
  • Disparities and Addressing Vaccination Hesitancy: Acknowledging disparities in vaccination rates, particularly among racial and ethnic minority groups, ACOG advocates for obstetric healthcare providers to actively recommend and advocate for influenza vaccination. Strategies include culturally responsive communication and engagement with community groups to address concerns and increase vaccination rates in underserved communities.

Influenza vaccination remains a pivotal aspect of obstetric care, significantly reducing the risk of severe illness in pregnant individuals. ACOG’s comprehensive recommendations emphasize the importance of healthcare providers’ recommendations, fostering confidence in vaccinations, and addressing disparities to ensure better outcomes for pregnant patients.

Reference:

Influenza in pregnancy: Prevention and treatment. (2023). Obstetrics and Gynecology, 10.1097/AOG.0000000000005479. https://doi.org/10.1097/aog.0000000000005479

Powered by WPeMatico

Control of Anthropometric Measures and Lipids may improve Gout Outcomes

A recent study, published in Rheumatic and Musculoskeletal Diseases, delved into the nuanced relationship between gout outcomes, lifestyle changes, and lipid levels. The research aimed to analyze the impact of anthropometric measures and lipid levels on gout outcomes in patients receiving treatment. Among the key determinants of gout outcomes, waist circumference and lipid levels emerged as crucial predictors.

Led by Dr. Till Uhlig and colleagues, the study included 211 patients with gout, predominantly male with an average age of 56.4 years. Over the 2-year duration, anthropometric measures remained relatively stable, whereas cholesterol and low-density lipoprotein cholesterol (LDL-C) showed a noticeable decrease by the end of the first year. Notably, high waist circumference (WC) and lipid levels emerged as strong predictors of unfavorable gout outcomes at the end of the 2-year period.

Patients with a recent gout flare and elevated serum urate levels received comprehensive gout education and were initiated on a ‘treat-to-target’ urate-lowering therapy over a year. Anthropometric measures including body mass index (BMI), waist circumference (WC), and waist-height ratio (WHR) were recorded yearly alongside lipid level assessments for the 2-year duration.

  • Proportion of Patients: Anthropometric measures remained largely unchanged over the 2-year study duration.
  • Cholesterol Levels: Demonstrated a reduction at the end of the first year.
  • Low-Density Lipoprotein Cholesterol (LDL-C): Showed a noticeable decrease by the end of the first year.
  • Association with Gout Outcomes: High waist circumference (WC) and elevated lipid levels were predictors of unfavorable gout outcomes after the 2-year study period.
  • Odds Ratio for Achieving sUA Target at Year 2:
  • WC: 0.96 per cm (95% CI: 0.93 to 0.99)
  • High-density lipoprotein cholesterol: 5.1 per mmol/L (95% CI: 1.2 to 22.1)
  • Odds Ratio for Gout Flare during Year 2:
  • High LDL-C: 1.8 per mmol/L (95% CI: 1.2 to 2.6)

The study’s findings underscore the significance of monitoring anthropometric measures and lipid levels in patients receiving continuous treatment for gout. Predictive relationships between high waist circumference, lipid levels, and unfavorable gout outcomes highlight the importance of managing these factors to optimize gout management strategies.

Reference:

Uhlig T, Karoliussen LF, Sexton J, Kvien TK, Haavardsholm EA, Hammer HB. Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study. RMD Open. 2023;9(4):e003600. Published 2023 Dec 1. doi:10.1136/rmdopen-2023-003600

Powered by WPeMatico

Doctors remove 300 kidney stones from woman who consumed bubble tea instead of water

More than 300 stones were removed from the kidney of a 20-year-old woman in Taiwan who used to hydrate herself only with beverages such as bubble tea, fruit juice, and alcoholic beverages for years instead of water.

For more news & updates, check out the link given below:

https://medicaldialogues.in/

Powered by WPeMatico

Ten Tips To Guard Your Lungs This Winter – Dr Raja Dhar

As winter approaches,
it’s crucial to understand how the changing weather can affect our breathing
and overall health. This overview breaks down the impact of seasonal shifts on
our respiratory well-being, focusing on things like the transition from warm to
cold weather, how it can affect people with existing lung problems and the
challenges posed by winter air pollution.

It is expected that there will be an
increase in respiratory issues, especially for kids, those with chronic lung
diseases, and older adults. In such times, children are more sensitive to air
quality, and parents should be mindful of outdoor plans.

Additionally, getting
vaccinated against various illnesses, is highlighted as a crucial step for
protection. Here are some practical tips to stay healthy, and avoid falling
prey to such illness, by taking care of your lungs and adopting healthy habits,
to enjoy a safe and healthy winter season.

1. Climate Impact on
Respiratory Health:

 
– Seasonal changes, especially from summer to winter, can lead to
increased viral replication in the upper respiratory tract.

 
– The transition from winter to warmer seasons may also trigger
respiratory issues, affecting both upper and lower airways.

2. Vulnerable Populations:

 
– Individuals with chronic lung diseases like asthma and COPD are at
higher risk of exacerbations during seasonal transitions.

 
– Hospitalization rates tend to rise significantly during the winter
period.

3. Air Pollution and Winter
Challenges:

 
– Post Diwali, air pollution intensifies due to a phenomenon called
‘temperature inversion.’

 
– Cold air traps pollutants at the earth’s surface, leading to poor air
quality and higher respiratory ailments.

4. 2023 Outlook:

 
– Anticipated increase in respiratory ailments in the next two months,
especially affecting children, those with chronic lung diseases, and the
elderly.

5. Additional Threats:

 
– New virus strains, including the reported COVID variants, pose risks,
particularly for individuals with comorbidities.

 
– Post-COVID symptoms may persist, with a continued risk of lung-related
issues for the next two years.

6. Preventive Measures:

 
– Avoid sudden temperature changes to prevent breathing passage spasms
and viral replication.

 
– Steer clear of chilled drinks and abrupt temperature shifts, such as
going from sweating to air conditioning.

 
– Quit smoking to protect both personal and public health.

7. Healthy Lifestyle Practices:

 
– Maintain a nutritious diet and engage in regular exercise.

 
– Exercise indoors during poor air quality to minimize exposure to
outdoor pollutants.

 
– Use masks, especially when the air quality index exceeds 150, to
mitigate the impact of pollutants.

8. Children’s Health
Considerations:

 
– Children are particularly vulnerable to ambient air particulate
matter, influencing school holiday schedules.

 
– Parents should stay vigilant and adapt plans based on air quality
conditions.

9. Vaccination Recommendations:

 
– Encourage vaccination against pneumonia, influenza, shingles,
pertussis, and stay updated on COVID vaccination guidelines.

10. Closing Thoughts:

 
– Emphasize the importance of healthy breathing and a positive
lifestyle.

 
– Wishing everyone a safe and healthy winter season.

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.

Powered by WPeMatico

COVID sub-variant JN.1 case detected in 79-year-old woman in Kerala

A case of COVID-19 sub-variant JN. 1 has been detected in Kerala as part of an ongoing routine surveillance activity of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a senior official from the Indian Council of Medical Research (ICMR) said on Saturday.

The case was detected in an RT-PCR positive sample from Karakulam in Thiruvananthapuram district of the southern state on December 8, Dr Rajiv Bahl, Director General of the ICMR, said.

For more news & updates, check out the link given below:

https://medicaldialogues.in/

Powered by WPeMatico

Sleep disturbances associated with emotional and behavioral difficulties in preschool children

China: A recent study published in JAMA Network Open has shed light on the importance of sleep health in promoting mental well-being in preschool-aged children.

The cohort study of 17 182 preschool-aged children in Shanghai, China, revealed a negative association between the incident and stable sleep disturbances and resolved emotional and behavioural difficulties (EBDs), and a positive association with incident EBDs after adjustment. Resolved sleep disturbances were positively associated with resolved EBDs.

“These findings underscore the association between sleep disturbances and emotional and behavioural difficulties among preschool-aged children and the importance of sleep health in promoting their mental well-being,” the researchers wrote in the study.

Mental health problems are the foremost cause of the global disease burden in children and adolescents. In preschool years, psychological disorders may have an early onset with documented changes in brain structure and function involved in emotion processing. Emotional and behavioural difficulties deserve particular attention in preschool-aged children due to their high prevalence and harmful effects on optimal mental health and functioning throughout childhood and later life.

Although EBDs may resolve with the growth of the child, 49.9% of young children still exhibit persistence one year after initial presentation. Furthermore, while early intervention in a clinical setting can improve childhood EBDs, multiple barriers such as stigma, high training demands, availability, and cost of services prevent children from receiving treatment.

Therefore, there is a need to identify both protective and risk factors that are modifiable in large community samples to prioritize more scalable and effective intervention and prevention strategies for EBDs in early childhood. Yujiao Deng, Shanghai Jiao Tong University, Shanghai, China, and colleagues investigated the association between the natural history of sleep disturbances and resolved and incident emotional and behavioural difficulties.

The researchers used data from the SCHEDULE-P, a prospective and population-based longitudinal cohort study of children enrolled in preschools in Shanghai, China. 20 324 children (3-4 years) were recruited from the junior class, of these 17 233 participated in the 2-year follow-up. The association between the development of sleep disturbances and the occurrence of incident and resolved EBDs were evaluated.

Sleep disturbances were evaluated using the Children’s Sleep Habit Questionnaire and EBDs were assessed using the Strengths and Difficulties Questionnaire.

Based on the study, the researchers reported the following findings:

  • The cohort included 17 182 participants, with a mean age of 3.73 years at enrollment; 52.0% were boys.
  • The prevalence of EBDs at school entry and graduation years was 27.8% and 18.7%, respectively, while the prevalence of sleep disturbances was 41.3% and 31.5%, respectively.
  • Among those with EBDs at the entry year, 35.0% maintained stability in the graduation year, while sleep disturbances were stable in 50.0% of those with sleep disturbances.
  • After controlling for confounding factors, the odds ratio (OR) for resolved EBDs was lower in the incident sleep disturbance (ISD) group (OR, 0.50) and stable sleep disturbance (SSD) group (OR, 0.47) compared with the group with no sleep disturbances.
  • The ORs for incident EBDs among the ISD group (OR, 2.58) and SSD group (OR, 2.29) were higher than among the group with no sleep disturbances.

“Our findings support the consistent integration of questions concerning sleep into routine developmental screenings in contexts of primary care and school,” the researchers wrote.

Furthermore, they suggest the need for intervention that targets symptoms of both sleep disturbance and EBDs to determine whether addressing these comorbidities can prevent their progression and effects on a child’s well-being.

Reference:

Deng Y, Zhang Z, Gui Y, et al. Sleep Disturbances and Emotional and Behavioral Difficulties Among Preschool-Aged Children. JAMA Netw Open. 2023;6(12):e2347623. doi:10.1001/jamanetworkopen.2023.47623

Powered by WPeMatico

Delhi: Factory producing duplicate of GSK’s Betnovate-N busted, mastermind held

New Delhi: A fake medical factory preparing duplicate ‘Betnovate-N’ was busted by the Delhi Police’s Crime Branch and 2,200 filled tubes and 68,000 empty tubes of the skin ointment seized, an official said on Sunday, adding that they have also arrested the mastermind.

The accused was identified as Avan Monga, 45, a resident of Vishnu Garden, Delhi.

Betnovate-N’ cream, a product of Glaxo Smith Kline (GSK) Company, is used for skin problems.

Special Commissioner of Police, Crime, Ravindra Singh Yadav said that from the last few months, reliable inputs were received that many duplicate cosmetics and medicines products are being manufactured by some entities.

A police team was assigned the task to develop information against such entities and information was gathered through manual as well technical sources.

“It was revealed that some entities situated in the Gulabi Bagh area are indulging in the illegal activity of manufacturing/stocking/ supplying/trading duplicate products of GSK Company. Authorised Enforcement officer of the company was contacted who also confirmed the same information with him,” the Special CP said.

The police team acted swiftly and a joint raid along with the Enforcement officer was conducted at the premises.

“During search, 57 cartons containing empty tubes of Betnovate-N cream were recovered from the factory, wherein each carton was found containing 1,200 tubes. Four cartons containing filled tubes of Betnovate-N cream were also recovered from the factory, wherein each carton was found containing 550 tubes,” said Yadav.

Other raw material and heavy Industrial machines which were being used for manufacturing were also seized.

During interrogation, the owner of the factory, Monga disclosed that he was running this factory for the last one year to gain a big margin. “He further disclosed that he used to get printed outer cover and tube of Betnovate-N from a printing press situated in outer Delhi and thereafter used it to fill/reseal the product in his factory,” the Special CP said.

Monga had spread this business in the area of outer Delhi and efforts are being made to unearth the whole chain, he added.

Read also: Gujarat: Fake antibiotic drugs, abortion-inducing medicines worth Rs 40 lakh seized

Powered by WPeMatico

What is the Connection between Diabetes and Vascular Disease? How to prevent Vascular Complications in Diabetes? – Dr Krishna Chaitanya

Diabetes is a
chronic condition that affects millions of people worldwide. Apart from its
well-known impact on blood sugar levels, diabetes can have a profound effect on
the vascular system. The interplay between diabetes and vascular health is
crucial, as individuals with diabetes are at a significantly higher risk of
developing vascular complications.

Vascular diseases include a range of
conditions such as atherosclerosis, peripheral artery disease (PAD), coronary
artery disease, and stroke, among others. Understanding how to prevent vascular
complications in diabetes is essential for improving the overall well-being of
those affected. This comprehensive guide will explore the steps you can take to
protect your vascular health and reduce the risk of complications associated
with diabetes.

The Diabetes-Vascular Disease Connection:

Before diving into prevention strategies, it’s crucial to comprehend
the link between diabetes and vascular complications. Diabetes, both type 1 and
type 2, can have detrimental effects on the vascular system. The elevated blood
sugar levels characteristic of diabetes can lead to a cascade of events that
damage blood vessels over time. Here’s how it happens:

High Blood Sugar Levels:

Uncontrolled diabetes results in consistently high levels of glucose
in the bloodstream. This excess sugar can injure the delicate inner lining of
blood vessels, leading to inflammation and the formation of fatty deposits.

Atherosclerosis:

Atherosclerosis, often referred to as “hardening of the
arteries,” is a condition where fatty deposits accumulate on the walls of
blood vessels. Over time, these deposits, known as plaques, can narrow and
block blood flow, increasing the risk of heart disease and stroke.

Microvascular Complications:

Diabetes can also affect the small blood vessels throughout the
body. This may lead to microvascular complications such as retinopathy (eye
damage), nephropathy (kidney damage), and neuropathy (nerve damage).

Preventing Vascular Complications:

Preventing vascular complications in diabetes involves a combination
of medical management, lifestyle changes, and proactive self-care. Here are
essential strategies for safeguarding your vascular health:

1. Blood Sugar Control

The cornerstone of diabetes management is controlling blood sugar
levels. Regular monitoring, medication adherence, and following your healthcare
provider’s guidance are crucial in maintaining optimal glucose levels.

2. Healthy Eating

A balanced diet that’s low in saturated and trans fats, cholesterol,
and sodium can significantly reduce the risk of atherosclerosis. Focus on
incorporating whole grains, fruits, vegetables, lean proteins, and healthy fats
into your meals.

3. Regular Physical Activity

Exercise plays a pivotal role in vascular health. It helps manage
blood sugar, lowers blood pressure, and keeps your weight in check. Aim for at
least 150 minutes of moderate-intensity exercise per week.

4. Medications

Your healthcare provider may prescribe medications to manage risk
factors such as high blood pressure, cholesterol, or blood-thinning agents.
Complying with your medication regimen is crucial.

5. Smoking Cessation

Smoking damages blood vessels and accelerates atherosclerosis. If
you smoke, seeking support to quit is one of the most significant steps you can
take to protect your vascular health.

6. Regular Check-Ups

Frequent check-ups with your healthcare provider are essential for
monitoring your vascular health. They can conduct tests to assess your risk
factors and identify issues in their early stages.

7. Foot Care

For individuals with diabetes, foot care is paramount. Nerve damage
can lead to reduced sensation in the feet, making them susceptible to injuries
and infections. Regularly inspect your feet, keep them clean and moisturized,
and choose appropriate footwear.

8. Medication Management

If you’ve been prescribed medications, follow your healthcare
provider’s instructions carefully. This includes taking prescribed dosages,
adhering to schedules, and reporting any side effects or concerns.

Conclusion:

Preventing vascular complications in diabetes is a proactive and
ongoing process. By adopting a comprehensive approach that combines medical
management, a heart-healthy lifestyle, and vigilant self-care, individuals with
diabetes can significantly reduce their risk of vascular issues.

Keep in mind
that personalized guidance from your healthcare provider is indispensable in
crafting a plan that suits your unique needs and circumstances. Protecting your
vascular health is an investment in your overall well-being and longevity.

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.

Powered by WPeMatico

Lupin, Sun Pharma recall rheumatoid arthritis, thyroid drugs in US

New Delhi: Leading drugmakers Sun Pharma and Lupin are recalling products in the US market over manufacturing issues, as per the US Food and Drug Administration (USFDA).

Mumbai-based Sun Pharmaceutical Industries is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US that are used to treat an underactive thyroid, according to the latest enforcement report issued by the American health regulator.

Princeton-based Sun Pharmaceutical Industries Inc, a unit of the company, is recalling the affected lot that was produced at the drugmaker’s Dadra-based facility. The company is recalling the lot due to ”failed impurities/degradation specifications”, the USFDA stated. The company commenced the voluntary nationwide Class II recall on December 4, this year.  

Read also: Zydus, Dr Reddy’s Labs and 1 other recall products in US over manufacturing issues

USFDA stated that Mumbai-based Lupin is also recalling an unspecified number of penicillamine tablets in the US. The medication is used to treat rheumatoid arthritis and Wilson’s disease. Baltimore-based Lupin Pharmaceuticals Inc, a unit of the company, is recalling the affected lot that was produced at the drugmaker’s Nagpur-based facility. As per the USFDA, the company is recalling the affected lot due to ”failed dissolution specifications”. The company initiated the Class II nationwide (US) voluntary recall on November 22.

Read also: Cipla US arm recalls Vigabatrin for Oral Solution, USP 500mg over pouch leakage issues

As per the USFDA, a class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. The Indian pharmaceutical industry is the third largest in the world by volume. The US is the world’s largest market for pharmaceutical products.

Read also: Sun Pharma arm recalls 144 bottles of anti-depression medicine in US over manufacturing issue

Powered by WPeMatico

Standards of Care in Diabetes 2024: ADA releases new recommendations for screening of PAD and heart failure

USA: The American Diabetes Association (ADA) has released new screening and obesity management recommendations for diabetes patients. The updated Standards of Care in Diabetes—2024 is available online and is published as a supplement to the January 2024 issue of Diabetes Care.

The ADA’s Standards of Care for 2024 include new recommendations to screen for heart failure, type 1 diabetes risk, and peripheral arterial disease (PAD), along with new obesity management guidance. It also includes new recommendations related to bone health and liver disease. The Standards of Care are essentially the global guidelines for the care of individuals with diabetes and those at risk.

The ADA’s Professional Practice Committee developed the document via a scientific literature review. The panel comprised 21 professionals, including physicians from many specialities, certified diabetes care and education specialists, nurse practitioners, pharmacists, and dieticians.

This article will mainly focus on the ADA’s updates on updated recommendations for screening peripheral arterial disease (PAD) and heart failure.

Atherosclerotic cardiovascular disease (ASCVD) defined as coronary heart disease (CHD), peripheral artery disease (PAD), or cerebrovascular disease is the leading cause of mortality and morbidity for people with diabetes. Addressing multiple cardiovascular risk factors (lipid control, glycemic, and blood pressure) can lead to large benefits.

Heart failure is another major cause of morbidity and mortality from cardiovascular disease.

The increased risk for heart failure in diabetic patients is classified as the presence of stage A heart failure, i.e., an increased risk for heart failure but without symptoms, structural heart disease, or biomarker evidence of myocardial strain. People with stage B heart failure are asymptomatic but have evidence of structural heart disease or functional cardiac abnormalities, including elevated biomarkers of myocardial strain or increased filling pressure. During these asymptomatic stages of heart failure, people with diabetes are at particularly high risk for progression to symptomatic stage C and D heart failure.

Recommendations For Heart Failure Screening 

  • The committee recommends considering screening asymptomatic adults with diabetes for the development of cardiac structural or functional abnormalities (stage B heart failure) by measurement of natriuretic peptides, including BNP or NT-proBNP levels.
  • Risk stratification for incident heart failure (stage A) and identification of people with asymptomatic cardiac abnormalities (stage B) may prevent progression to the symptomatic stages of heart failure (stages C and D).
  • People with diabetes and an elevated natriuretic peptide level without any symptoms of heart failure should be considered to have stage B heart failure, as there is evidence for increased filling pressure and wall strain.
  • In people with diabetes and an abnormal natriuretic peptide level, echocardiography is recommended as the next step to screen for structural heart disease and echocardiographic Doppler indices for evidence of diastolic dysfunction and increased filling pressures.

Screening for Asymptomatic Peripheral Artery Disease in People With Diabetes

  • The committee recommends screening for asymptomatic PAD using ankle-brachial index in people with diabetes at high risk for PAD, including any of the following: age ≥50 years, diabetes with duration ≥10 years, comorbid microvascular disease, clinical evidence of foot complications, or any end-organ damage from diabetes.
  • The committee recommends screening people with diabetes and high risk for PAD, including those aged≥50 years, diabetes with duration ≥10 years, microvascular disease, clinical evidence of foot complications, or any end-organ damage from diabetes.

Screening for asymptomatic PAD may lead to early detection and treatment strategies to reduce the risk for progression of PAD and limb preservation. In addition, secondary prevention of PAD has been shown to reduce adverse cardiovascular and limb outcomes.

Reference:

American Diabetes Association Professional Practice Committee; 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024. Diabetes Care 1 January 2024; 47 (Supplement_1): S179–S218. https://doi.org/10.2337/dc24-S010

Powered by WPeMatico